LifePoint Health, Inc. (NASDAQ:LPNT) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.92-$4.20 for the period, compared to the Thomson Reuters consensus estimate of $4.19. The company issued revenue guidance of $6.425-$6.500 billion, compared to the consensus revenue estimate of $6.55 billion.
Several research firms recently commented on LPNT. BidaskClub lowered shares of LifePoint Health from a buy rating to a hold rating in a research report on Saturday, July 8th. Zacks Investment Research lowered shares of LifePoint Health from a buy rating to a hold rating in a research report on Tuesday, July 11th. ValuEngine upgraded shares of LifePoint Health from a hold rating to a buy rating in a research report on Thursday. TheStreet lowered shares of LifePoint Health from a b- rating to a c+ rating in a research report on Wednesday. Finally, Royal Bank Of Canada restated a buy rating and set a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of $66.18.
LifePoint Health, Inc. (NASDAQ:LPNT) opened at 57.45 on Friday. The stock has a market capitalization of $2.30 billion, a P/E ratio of 12.86 and a beta of 0.86. LifePoint Health, Inc. has a 52 week low of $50.60 and a 52 week high of $70.95. The firm’s 50-day moving average is $61.96 and its 200-day moving average is $62.71.
In other news, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the transaction, the chairman now directly owns 504,535 shares in the company, valued at approximately $32,365,920.25. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman William F. Carpenter III sold 17,653 shares of the stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the transaction, the chairman now owns 439,841 shares in the company, valued at $28,616,055.46. The disclosure for this sale can be found here. Corporate insiders own 7.28% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “LifePoint Health, Inc. (LPNT) Issues FY17 Earnings Guidance” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/lifepoint-health-inc-lpnt-issues-fy17-earnings-guidance-updated-updated.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.